Listed

NEUROONE MEDICAL TECHNOLOGIES Corp

NMTCNasdaqCIK 1500198HealthcareFiscal year ends Sep 30

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$2.0m, Q3 FY2026
Operating income−$2.4m, Q3 FY2026
Net income−$2.0m, Q3 FY2026
NEUROONE MEDICAL TECHNOLOGIES Corp, income statement, quarterly
Line itemUnitQ4 FY20232023-09-30Q1 FY20242023-12-31Q2 FY20242024-03-31Q3 FY20242024-06-30Q4 FY20242024-09-30Q1 FY20252024-12-31Q2 FY20252025-03-31Q3 FY20252025-06-30Q4 FY20252025-09-30Q1 FY20262025-12-31Q2 FY20262026-03-31Q3 FY20262026-06-30
Revenue$k742Revenue, Q4 FY2023, three months to 2023-09-30$741.8k. XBRL concept us-gaap:Revenues. 10-K filed 2024-12-17, accession 0001213900-24-109524. Derived: 12-month figure less the 9-month figure.Report this figure978Revenue, Q1 FY2024, three months to 2023-12-31$977.6k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-02-12, accession 0001213900-25-012511.Report this figure1,377Revenue, Q2 FY2024, three months to 2024-03-31$1.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-13, accession 0001213900-25-042266.Report this figure826Revenue, Q3 FY2024, three months to 2024-06-30$825.8k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure272Revenue, Q4 FY2024, three months to 2024-09-30$272.3k. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure3,274Revenue, Q1 FY2025, three months to 2024-12-31$3.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure1,387Revenue, Q2 FY2025, three months to 2025-03-31$1.4m. XBRL concept us-gaap:Revenues. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure1,696Revenue, Q3 FY2025, three months to 2025-06-30$1.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure2,741Revenue, Q4 FY2025, three months to 2025-09-30$2.7m. XBRL concept us-gaap:Revenues. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure2,893Revenue, Q1 FY2026, three months to 2025-12-31$2.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure1,862Revenue, Q2 FY2026, three months to 2026-03-31$1.9m. XBRL concept us-gaap:Revenues. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure1,973Revenue, Q3 FY2026, three months to 2026-06-30$2.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure
Cost of revenue$k548Cost of revenue, Q4 FY2023, three months to 2023-09-30$548.1k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2024-12-17, accession 0001213900-24-109524. Derived: 12-month figure less the 9-month figure.Report this figure711Cost of revenue, Q1 FY2024, three months to 2023-12-31$711.3k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-02-12, accession 0001213900-25-012511.Report this figure987Cost of revenue, Q2 FY2024, three months to 2024-03-31$986.9k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-13, accession 0001213900-25-042266.Report this figure544Cost of revenue, Q3 FY2024, three months to 2024-06-30$543.9k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure131Cost of revenue, Q4 FY2024, three months to 2024-09-30$131.2k. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure1,347Cost of revenue, Q1 FY2025, three months to 2024-12-31$1.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure615Cost of revenue, Q2 FY2025, three months to 2025-03-31$615.5k. XBRL concept us-gaap:CostOfRevenue. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure781Cost of revenue, Q3 FY2025, three months to 2025-06-30$781.2k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure1,212Cost of revenue, Q4 FY2025, three months to 2025-09-30$1.2m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure1,325Cost of revenue, Q1 FY2026, three months to 2025-12-31$1.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure872Cost of revenue, Q2 FY2026, three months to 2026-03-31$871.8k. XBRL concept us-gaap:CostOfRevenue. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure790Cost of revenue, Q3 FY2026, three months to 2026-06-30$790.5k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure
Gross profit$k194Gross profit, Q4 FY2023, three months to 2023-09-30$193.7k. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-12-17, accession 0001213900-24-109524. Derived: 12-month figure less the 9-month figure.Report this figure266Gross profit, Q1 FY2024, three months to 2023-12-31$266.3k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-02-12, accession 0001213900-25-012511.Report this figure390Gross profit, Q2 FY2024, three months to 2024-03-31$390.4k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-13, accession 0001213900-25-042266.Report this figure282Gross profit, Q3 FY2024, three months to 2024-06-30$281.9k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure141Gross profit, Q4 FY2024, three months to 2024-09-30$141.1k. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure1,927Gross profit, Q1 FY2025, three months to 2024-12-31$1.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure771Gross profit, Q2 FY2025, three months to 2025-03-31$771.1k. XBRL concept us-gaap:GrossProfit. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure915Gross profit, Q3 FY2025, three months to 2025-06-30$914.8k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure1,529Gross profit, Q4 FY2025, three months to 2025-09-30$1.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure1,568Gross profit, Q1 FY2026, three months to 2025-12-31$1.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure990Gross profit, Q2 FY2026, three months to 2026-03-31$990.3k. XBRL concept us-gaap:GrossProfit. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure1,183Gross profit, Q3 FY2026, three months to 2026-06-30$1.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure
Research and development$k1,779Research and development, Q4 FY2023, three months to 2023-09-30$1.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2024-12-17, accession 0001213900-24-109524. Derived: 12-month figure less the 9-month figure.Report this figure1,483Research and development, Q1 FY2024, three months to 2023-12-31$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-12, accession 0001213900-25-012511.Report this figure1,274Research and development, Q2 FY2024, three months to 2024-03-31$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0001213900-25-042266.Report this figure1,195Research and development, Q3 FY2024, three months to 2024-06-30$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure1,114Research and development, Q4 FY2024, three months to 2024-09-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure1,172Research and development, Q1 FY2025, three months to 2024-12-31$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure1,511Research and development, Q2 FY2025, three months to 2025-03-31$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure1,182Research and development, Q3 FY2025, three months to 2025-06-30$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure1,118Research and development, Q4 FY2025, three months to 2025-09-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure1,390Research and development, Q1 FY2026, three months to 2025-12-31$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure1,468Research and development, Q2 FY2026, three months to 2026-03-31$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure1,425Research and development, Q3 FY2026, three months to 2026-06-30$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure
Selling, general and administrative$k1,579Selling, general and administrative, Q4 FY2023, three months to 2023-09-30$1.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2024-12-17, accession 0001213900-24-109524. Derived: 12-month figure less the 9-month figure.Report this figure2,173Selling, general and administrative, Q1 FY2024, three months to 2023-12-31$2.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-02-12, accession 0001213900-25-012511.Report this figure2,003Selling, general and administrative, Q2 FY2024, three months to 2024-03-31$2.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-13, accession 0001213900-25-042266.Report this figure1,881Selling, general and administrative, Q3 FY2024, three months to 2024-06-30$1.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure1,844Selling, general and administrative, Q4 FY2024, three months to 2024-09-30$1.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure2,043Selling, general and administrative, Q1 FY2025, three months to 2024-12-31$2.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure1,940Selling, general and administrative, Q2 FY2025, three months to 2025-03-31$1.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure1,619Selling, general and administrative, Q3 FY2025, three months to 2025-06-30$1.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure1,782Selling, general and administrative, Q4 FY2025, three months to 2025-09-30$1.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure1,885Selling, general and administrative, Q1 FY2026, three months to 2025-12-31$1.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure1,919Selling, general and administrative, Q2 FY2026, three months to 2026-03-31$1.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure2,182Selling, general and administrative, Q3 FY2026, three months to 2026-06-30$2.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure
Operating income$k(3,165)Operating income, Q4 FY2023, three months to 2023-09-30−$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-12-17, accession 0001213900-24-109524. Derived: 12-month figure less the 9-month figure.Report this figure(3,390)Operating income, Q1 FY2024, three months to 2023-12-31−$3.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-12, accession 0001213900-25-012511.Report this figure(2,886)Operating income, Q2 FY2024, three months to 2024-03-31−$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001213900-25-042266.Report this figure(2,794)Operating income, Q3 FY2024, three months to 2024-06-30−$2.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure(2,817)Operating income, Q4 FY2024, three months to 2024-09-30−$2.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure1,711Operating income, Q1 FY2025, three months to 2024-12-31$1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure(2,680)Operating income, Q2 FY2025, three months to 2025-03-31−$2.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure(1,887)Operating income, Q3 FY2025, three months to 2025-06-30−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure(1,371)Operating income, Q4 FY2025, three months to 2025-09-30−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure(1,707)Operating income, Q1 FY2026, three months to 2025-12-31−$1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure(2,397)Operating income, Q2 FY2026, three months to 2026-03-31−$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure(2,424)Operating income, Q3 FY2026, three months to 2026-06-30−$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure
Interest expense$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$k(3,135)Net income, Q4 FY2023, three months to 2023-09-30−$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-12-17, accession 0001213900-24-109524. Derived: 12-month figure less the 9-month figure.Report this figure(3,345)Net income, Q1 FY2024, three months to 2023-12-31−$3.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure(2,855)Net income, Q2 FY2024, three months to 2024-03-31−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure(2,768)Net income, Q3 FY2024, three months to 2024-06-30−$2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure(3,351)Net income, Q4 FY2024, three months to 2024-09-30−$3.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure1,785Net income, Q1 FY2025, three months to 2024-12-31$1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure(2,271)Net income, Q2 FY2025, three months to 2025-03-31−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure(1,501)Net income, Q3 FY2025, three months to 2025-06-30−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure(1,619)Net income, Q4 FY2025, three months to 2025-09-30−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure(1,438)Net income, Q1 FY2026, three months to 2025-12-31−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure(2,382)Net income, Q2 FY2026, three months to 2026-03-31−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure(2,006)Net income, Q3 FY2026, three months to 2026-06-30−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure
Diluted EPS$ per sharenot reported(0.14)Diluted EPS, Q1 FY2024, three months to 2023-12-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-12, accession 0001213900-25-012511.Report this figure(0.11)Diluted EPS, Q2 FY2024, three months to 2024-03-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0001213900-25-042266.Report this figure(0.10)Diluted EPS, Q3 FY2024, three months to 2024-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figurenot reported0.06Diluted EPS, Q1 FY2025, three months to 2024-12-31$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure(0.44)Diluted EPS, Q2 FY2025, three months to 2025-03-31−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure(0.19)Diluted EPS, Q3 FY2025, three months to 2025-06-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figurenot reported(0.03)Diluted EPS, Q1 FY2026, three months to 2025-12-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure(0.28)Diluted EPS, Q2 FY2026, three months to 2026-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure(0.28)Diluted EPS, Q3 FY2026, three months to 2026-06-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure
Basic EPS$ per sharenot reported(0.14)Basic EPS, Q1 FY2024, three months to 2023-12-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-12, accession 0001213900-25-012511.Report this figure(0.11)Basic EPS, Q2 FY2024, three months to 2024-03-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0001213900-25-042266.Report this figure(0.10)Basic EPS, Q3 FY2024, three months to 2024-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figurenot reported0.06Basic EPS, Q1 FY2025, three months to 2024-12-31$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure(0.44)Basic EPS, Q2 FY2025, three months to 2025-03-31−$0.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure(0.19)Basic EPS, Q3 FY2025, three months to 2025-06-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figurenot reported(0.03)Basic EPS, Q1 FY2026, three months to 2025-12-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure(0.28)Basic EPS, Q2 FY2026, three months to 2026-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure(0.23)Basic EPS, Q3 FY2026, three months to 2026-06-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure

Balance sheet

Cash and equivalents$2.0m, Q3 FY2026
Shareholders' equity$3.8m, Q3 FY2026
NEUROONE MEDICAL TECHNOLOGIES Corp, balance sheet, quarterly
Line itemUnitFY20232023-09-30Q1 FY20242023-12-31Q2 FY20242024-03-31Q3 FY20242024-06-30FY20242024-09-30Q1 FY20252024-12-31Q2 FY20252025-03-31Q3 FY20252025-06-30FY20252025-09-30Q1 FY20262025-12-31Q2 FY20262026-03-31Q3 FY20262026-06-30
Cash and equivalents$m5.3Cash and equivalents, FY2023, at 2023-09-30$5.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2024-12-17, accession 0001213900-24-109524.Report this figure2.7Cash and equivalents, Q1 FY2024, at 2023-12-31$2.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-02-13, accession 0001213900-24-013276.Report this figure2.4Cash and equivalents, Q2 FY2024, at 2024-03-31$2.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001213900-24-042948.Report this figure1.6Cash and equivalents, Q3 FY2024, at 2024-06-30$1.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001213900-24-068633.Report this figure1.5Cash and equivalents, FY2024, at 2024-09-30$1.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-12-17, accession 0001213900-25-122390.Report this figure1.1Cash and equivalents, Q1 FY2025, at 2024-12-31$1.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-12, accession 0001213900-25-012511.Report this figure1.3Cash and equivalents, Q2 FY2025, at 2025-03-31$1.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0001213900-25-042266.Report this figure8.0Cash and equivalents, Q3 FY2025, at 2025-06-30$8.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure6.6Cash and equivalents, FY2025, at 2025-09-30$6.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure3.6Cash and equivalents, Q1 FY2026, at 2025-12-31$3.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure2.8Cash and equivalents, Q2 FY2026, at 2026-03-31$2.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure2.0Cash and equivalents, Q3 FY2026, at 2026-06-30$2.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure
Current assets$m7.3Current assets, FY2023, at 2023-09-30$7.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2024-12-17, accession 0001213900-24-109524.Report this figure5.1Current assets, Q1 FY2024, at 2023-12-31$5.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-02-13, accession 0001213900-24-013276.Report this figure4.7Current assets, Q2 FY2024, at 2024-03-31$4.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001213900-24-042948.Report this figure4.1Current assets, Q3 FY2024, at 2024-06-30$4.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001213900-24-068633.Report this figure4.6Current assets, FY2024, at 2024-09-30$4.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-12-17, accession 0001213900-25-122390.Report this figure5.7Current assets, Q1 FY2025, at 2024-12-31$5.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-12, accession 0001213900-25-012511.Report this figure3.8Current assets, Q2 FY2025, at 2025-03-31$3.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0001213900-25-042266.Report this figure10.2Current assets, Q3 FY2025, at 2025-06-30$10.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure10.2Current assets, FY2025, at 2025-09-30$10.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure8.1Current assets, Q1 FY2026, at 2025-12-31$8.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure7.1Current assets, Q2 FY2026, at 2026-03-31$7.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure5.8Current assets, Q3 FY2026, at 2026-06-30$5.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure
Total assets$m8.1Total assets, FY2023, at 2023-09-30$8.1m. XBRL concept us-gaap:Assets. 10-K filed 2024-12-17, accession 0001213900-24-109524.Report this figure5.8Total assets, Q1 FY2024, at 2023-12-31$5.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-02-13, accession 0001213900-24-013276.Report this figure5.4Total assets, Q2 FY2024, at 2024-03-31$5.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001213900-24-042948.Report this figure4.9Total assets, Q3 FY2024, at 2024-06-30$4.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001213900-24-068633.Report this figure5.4Total assets, FY2024, at 2024-09-30$5.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-12-17, accession 0001213900-25-122390.Report this figure6.5Total assets, Q1 FY2025, at 2024-12-31$6.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-12, accession 0001213900-25-012511.Report this figure4.5Total assets, Q2 FY2025, at 2025-03-31$4.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0001213900-25-042266.Report this figure10.8Total assets, Q3 FY2025, at 2025-06-30$10.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure10.8Total assets, FY2025, at 2025-09-30$10.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure8.6Total assets, Q1 FY2026, at 2025-12-31$8.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure7.6Total assets, Q2 FY2026, at 2026-03-31$7.6m. XBRL concept us-gaap:Assets. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure6.2Total assets, Q3 FY2026, at 2026-06-30$6.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure
Current liabilities$m1.8Current liabilities, FY2023, at 2023-09-30$1.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2024-12-17, accession 0001213900-24-109524.Report this figure1.4Current liabilities, Q1 FY2024, at 2023-12-31$1.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-02-13, accession 0001213900-24-013276.Report this figure1.5Current liabilities, Q2 FY2024, at 2024-03-31$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001213900-24-042948.Report this figure1.7Current liabilities, Q3 FY2024, at 2024-06-30$1.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001213900-24-068633.Report this figure2.2Current liabilities, FY2024, at 2024-09-30$2.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-12-17, accession 0001213900-25-122390.Report this figure1.6Current liabilities, Q1 FY2025, at 2024-12-31$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-12, accession 0001213900-25-012511.Report this figure1.8Current liabilities, Q2 FY2025, at 2025-03-31$1.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0001213900-25-042266.Report this figure1.4Current liabilities, Q3 FY2025, at 2025-06-30$1.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure2.3Current liabilities, FY2025, at 2025-09-30$2.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure1.3Current liabilities, Q1 FY2026, at 2025-12-31$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure1.7Current liabilities, Q2 FY2026, at 2026-03-31$1.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure2.0Current liabilities, Q3 FY2026, at 2026-06-30$2.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure
Total liabilities$m1.8Total liabilities, FY2023, at 2023-09-30$1.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2024-12-17, accession 0001213900-24-109524.Report this figure1.4Total liabilities, Q1 FY2024, at 2023-12-31$1.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-02-13, accession 0001213900-24-013276.Report this figure1.5Total liabilities, Q2 FY2024, at 2024-03-31$1.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001213900-24-042948.Report this figure1.9Total liabilities, Q3 FY2024, at 2024-06-30$1.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001213900-24-068633.Report this figure4.5Total liabilities, FY2024, at 2024-09-30$4.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-12-17, accession 0001213900-25-122390.Report this figure3.6Total liabilities, Q1 FY2025, at 2024-12-31$3.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-12, accession 0001213900-25-012511.Report this figure3.3Total liabilities, Q2 FY2025, at 2025-03-31$3.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0001213900-25-042266.Report this figure2.6Total liabilities, Q3 FY2025, at 2025-06-30$2.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure3.7Total liabilities, FY2025, at 2025-09-30$3.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure2.2Total liabilities, Q1 FY2026, at 2025-12-31$2.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure2.5Total liabilities, Q2 FY2026, at 2026-03-31$2.5m. XBRL concept us-gaap:Liabilities. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure2.4Total liabilities, Q3 FY2026, at 2026-06-30$2.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure
Short-term borrowings$m0.1Short-term borrowings, FY2023, at 2023-09-30$129.1k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2024-05-14, accession 0001213900-24-042948.Report this figurenot reported0.1Short-term borrowings, Q2 FY2024, at 2024-03-31$121.9k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2024-05-14, accession 0001213900-24-042948.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m6.2Shareholders' equity, FY2023, at 2023-09-30$6.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-12-17, accession 0001213900-25-122390.Report this figure4.4Shareholders' equity, Q1 FY2024, at 2023-12-31$4.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure3.9Shareholders' equity, Q2 FY2024, at 2024-03-31$3.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure3.0Shareholders' equity, Q3 FY2024, at 2024-06-30$3.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure0.8Shareholders' equity, FY2024, at 2024-09-30$822.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure2.9Shareholders' equity, Q1 FY2025, at 2024-12-31$2.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure1.1Shareholders' equity, Q2 FY2025, at 2025-03-31$1.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure8.2Shareholders' equity, Q3 FY2025, at 2025-06-30$8.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure7.1Shareholders' equity, FY2025, at 2025-09-30$7.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure6.4Shareholders' equity, Q1 FY2026, at 2025-12-31$6.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure5.1Shareholders' equity, Q2 FY2026, at 2026-03-31$5.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure3.8Shareholders' equity, Q3 FY2026, at 2026-06-30$3.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure

Cash flow

Operating cash flow−$1.1m, Q3 FY2026
Capital expenditure$19.7k, Q3 FY2026
NEUROONE MEDICAL TECHNOLOGIES Corp, cash flow, quarterly
Line itemUnitQ4 FY20232023-09-30Q1 FY20242023-12-31Q2 FY20242024-03-31Q3 FY20242024-06-30Q4 FY20242024-09-30Q1 FY20252024-12-31Q2 FY20252025-03-31Q3 FY20252025-06-30Q4 FY20252025-09-30Q1 FY20262025-12-31Q2 FY20262026-03-31Q3 FY20262026-06-30
Operating cash flow$k(2,903)Operating cash flow, Q4 FY2023, three months to 2023-09-30−$2.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-12-17, accession 0001213900-24-109524. Derived: 12-month figure less the 9-month figure.Report this figure(3,809)Operating cash flow, Q1 FY2024, three months to 2023-12-31−$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-12, accession 0001213900-25-012511.Report this figure(2,175)Operating cash flow, Q2 FY2024, three months to 2024-03-31−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001213900-25-042266. Derived: 6-month figure less the 3-month figure.Report this figure(2,360)Operating cash flow, Q3 FY2024, three months to 2024-06-30−$2.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001213900-25-076080. Derived: 9-month figure less the 6-month figure.Report this figure(2,667)Operating cash flow, Q4 FY2024, three months to 2024-09-30−$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure208Operating cash flow, Q1 FY2025, three months to 2024-12-31$208.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure(56.1)Operating cash flow, Q2 FY2025, three months to 2025-03-31−$56.1k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307. Derived: 6-month figure less the 3-month figure.Report this figure(1,464)Operating cash flow, Q3 FY2025, three months to 2025-06-30−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001213900-26-088724. Derived: 9-month figure less the 6-month figure.Report this figure(1,526)Operating cash flow, Q4 FY2025, three months to 2025-09-30−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure(3,116)Operating cash flow, Q1 FY2026, three months to 2025-12-31−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure(1,329)Operating cash flow, Q2 FY2026, three months to 2026-03-31−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307. Derived: 6-month figure less the 3-month figure.Report this figure(1,082)Operating cash flow, Q3 FY2026, three months to 2026-06-30−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001213900-26-088724. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$k57.6Capital expenditure, Q4 FY2023, three months to 2023-09-30$57.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-12-17, accession 0001213900-24-109524. Derived: 12-month figure less the 9-month figure.Report this figure37.1Capital expenditure, Q1 FY2024, three months to 2023-12-31$37.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-02-13, accession 0001213900-24-013276.Report this figure31.4Capital expenditure, Q2 FY2024, three months to 2024-03-31$31.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-05-14, accession 0001213900-24-042948. Derived: 6-month figure less the 3-month figure.Report this figure14.8Capital expenditure, Q3 FY2024, three months to 2024-06-30$14.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0001213900-25-076080. Derived: 9-month figure less the 6-month figure.Report this figure36.9Capital expenditure, Q4 FY2024, three months to 2024-09-30$36.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure24.4Capital expenditure, Q1 FY2025, three months to 2024-12-31$24.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure3.2Capital expenditure, Q2 FY2025, three months to 2025-03-31$3.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307. Derived: 6-month figure less the 3-month figure.Report this figure43.5Capital expenditure, Q3 FY2025, three months to 2025-06-30$43.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001213900-26-088724. Derived: 9-month figure less the 6-month figure.Report this figure10.6Capital expenditure, Q4 FY2025, three months to 2025-09-30$10.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-12-17, accession 0001213900-25-122390. Derived: 12-month figure less the 9-month figure.Report this figure40.8Capital expenditure, Q1 FY2026, three months to 2025-12-31$40.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure38.5Capital expenditure, Q2 FY2026, three months to 2026-03-31$38.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307. Derived: 6-month figure less the 3-month figure.Report this figure19.7Capital expenditure, Q3 FY2026, three months to 2026-06-30$19.7k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001213900-26-088724. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)8.74m, Q3 FY2026
NEUROONE MEDICAL TECHNOLOGIES Corp, shares, quarterly
Line itemUnitQ1 FY20232022-12-31Q2 FY20232023-03-31Q3 FY20232023-06-30Q1 FY20242023-12-31Q2 FY20242024-03-31Q3 FY20242024-06-30Q1 FY20252024-12-31Q2 FY20252025-03-31Q3 FY20252025-06-30Q1 FY20262025-12-31Q2 FY20262026-03-31Q3 FY20262026-06-30
Diluted shares (weighted)m shares16.2Diluted shares (weighted), Q1 FY2023, three months to 2022-12-3116,230,997 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-02-13, accession 0001213900-24-013276.Report this figure16.4Diluted shares (weighted), Q2 FY2023, three months to 2023-03-3116,414,795 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001213900-24-042948.Report this figure17.6Diluted shares (weighted), Q3 FY2023, three months to 2023-06-3017,578,871 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001213900-24-068633.Report this figure24.0Diluted shares (weighted), Q1 FY2024, three months to 2023-12-3123,995,610 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-02-12, accession 0001213900-25-012511.Report this figure25.9Diluted shares (weighted), Q2 FY2024, three months to 2024-03-3125,910,478 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0001213900-25-042266.Report this figure27.4Diluted shares (weighted), Q3 FY2024, three months to 2024-06-3027,352,660 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001213900-25-076080.Report this figure30.9Diluted shares (weighted), Q1 FY2025, three months to 2024-12-3130,880,415 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure5.2Diluted shares (weighted), Q2 FY2025, three months to 2025-03-315,185,075 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure8.1Diluted shares (weighted), Q3 FY2025, three months to 2025-06-308,100,603 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure50.3Diluted shares (weighted), Q1 FY2026, three months to 2025-12-3150,331,155 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-02-17, accession 0001213900-26-016860.Report this figure8.5Diluted shares (weighted), Q2 FY2026, three months to 2026-03-318,484,926 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q/A filed 2026-06-12, accession 0001213900-26-068307.Report this figure8.7Diluted shares (weighted), Q3 FY2026, three months to 2026-06-308,739,505 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure

Shares outstanding: 9.11mShares outstanding, period not labelled, at 2026-08-119,105,763 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001213900-26-088724.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. Listed shows no prices and gives no investment advice.